Biotech Scan

Scan

Biotech Scan

Scan symbols 11
ALNYBEAMBIIBBNTXCRSPEDITGILDLEGNLLYMRNANTLA
Watchlists 1
@biotech-scan
raw scan snapshot — prices as of scan date, not live 22 rows · screens, not recommendations superseded by2026-04-26-biotech-scanported fromresearch/classic/scans/_archive/2026-02-11-biotech-scan.mdscan slugbiotech-scansource typescan-archive

Biotech bifurcated: pharma ripping (GILD RSI 90, BIIB RSI 79), gene therapy in capitulation (LEGN RSI 8, CRSP RSI 44, BEAM RSI 38).

Quick Snapshot

Signal Reading
Overall 🟡 SPLIT — Large-cap pharma parabolic, gene therapy/biotech crushed. ARKG RSI 43.
Best setup LEGN $17 RSI 8 — most oversold in entire universe. Extreme risk/reward.
Avoid GILD RSI 90, BIIB RSI 79 — don't chase defensive pharma.

Biotech Universe (Validated 2026-02-11)

Stock Price RSI SMA20 vs SMA Signal Category
GILD $150.76 90 $136.00 +10.9% 🔴 Overbought Large-cap pharma
BIIB $195.42 79 $177.55 +10.1% 🔴 Extended Large-cap pharma
LLY $1050.57 51 $1052.30 -0.2% 🟡 Neutral GLP-1 leader
BNTX $109.51 55 $111.16 -1.5% 🟡 Neutral mRNA platform
ALNY $321.73 33 $352.49 -8.7% 🔴 Oversold RNAi leader
MRNA $41.18 46 $43.44 -5.2% 🟡 Below SMA mRNA struggling
CRSP $48.88 44 $53.13 -8.0% 🟡 Weak Gene editing leader
BEAM $27.10 38 $30.18 -10.2% 🔴 Oversold Base editing
NTLA $12.27 47 $13.04 -5.9% 🟡 Below SMA In vivo gene editing
EDIT $1.77 42 $2.04 -13.2% 🔴 Weak Gene editing, micro-cap
LEGN $17.20 8 $19.40 -11.3% 🔴 Capitulation CAR-T, extreme oversold

Tier Analysis

Tier 1: Capitulation Zone (RSI < 25)

Stock Price RSI Signal Risk
LEGN $17.20 8 🔴 Extreme High — could be broken or massive bounce

Tier 2: Oversold (RSI 25-40)

Stock Price RSI Entry Zone Action
ALNY $321.73 33 $310-325 🟡 Watch — RNAi leader, quality
BEAM $27.10 38 $25-28 🟡 Watch — base editing pioneer

Tier 3: Neutral

Stock RSI Action
CRSP 44 🟡 Improving from lows, hold
MRNA 46 🟡 No catalyst
NTLA 47 🟡 No catalyst

Tier 4: Overbought (Don't Chase)

Stock RSI Action
GILD 90 🔴 Extremely overbought, trim if holding
BIIB 79 🔴 Extended, don't add

Key Signals

  • LEGN RSI 8 — Most oversold stock in the entire universe. CAR-T therapy company. Extreme risk/reward.
  • GILD RSI 90 — Most overbought. Defensive rotation into pharma. Don't chase.
  • Gene therapy basket (CRSP, BEAM, EDIT, NTLA, LEGN) all weak — sector-wide headwind.
  • ALNY interesting: RNAi leader at RSI 33, 8.7% below SMA. Quality at discount.
  • ARKG ETF RSI 43 — innovation biotech still under pressure.
10 events
DateTypeEvent
Feb 16 ScanBiotech Scan Feb 5 ScanBiotech Scan Feb 11 UpdateBiotech Feb 22 ScanBiotech Scan Feb 9 ScanBiotech Scan Feb 16 UpdateBiotech Feb 26 ScanBiotech Scan Mar 3 ScanBiotech Scan Feb 22 UpdateBiotech Feb 26 UpdateBiotech

No direct external sources are attached to this read.